Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery
Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also...
Saved in:
Published in | BMC surgery Vol. 24; no. 1; pp. 416 - 11 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
23.12.2024
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2482 1471-2482 |
DOI | 10.1186/s12893-024-02697-5 |
Cover
Loading…
Abstract | Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.
The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.
Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.
There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. |
---|---|
AbstractList | BackgroundLateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.MethodsThe subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.ResultsOf the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.ConclusionsThere was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.BACKGROUNDLateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction.The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.METHODSThe subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC.Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.RESULTSOf the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC.There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function.CONCLUSIONSThere was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. The subjects were 100 patients with LARC ([greater than or equal to] cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at [less than or equal to] 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. Abstract Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. Methods The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Results Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. Conclusions There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. Methods The subjects were 100 patients with LARC ([greater than or equal to] cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at [less than or equal to] 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Results Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. Conclusions There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. Keywords: Lateral lymph node resection, Urinary dysfunction, Removal of urinary catheter, Duration of urinary catheterization, Robot-assisted laparoscopic surgery, Laparoscopic surgery, Rectal cancer Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some disadvantages to LLND, including technical difficulties and association with postoperative urinary dysfunction. Procedures for LARC have also become more minimally invasive: laparoscopic surgery (LS) has become more common, and use of robot-assisted LS (RALS) is increasing. The purpose of this study is to assess differences in postoperative urinary dysfunction after LLND for LARC between LS and RALS, and to identify risk factors for postoperative urinary dysfunction. The subjects were 100 patients with LARC (≥ cT3) with the inferior border of the tumor reaching the peritoneal reflection who underwent LS or RALS with LLND between 2009 and 2023 at Juntendo University Hospital. After LLND, the urinary catheter was usually removed on or before postoperative day 5. The duration of urinary catheterization (DUC) was used to evaluate postoperative urinary dysfunction. The standard (S) and long-term (L) groups were defined as cases with urinary catheter removal at ≤ 5 and > 5 days, respectively. DUC was examined for LS vs. RALS and clinicopathological factors were identified that adversely affect DUC. Of the 100 subjects, 72 underwent LS and 28 received RALS. LLND was bilateral in 65 cases and unilateral in 35 cases. The median DUC was 5 days, with 74 cases in group S and 26 in group L. The most frequent postoperative complication (Clavien-Dindo Grade 2 or higher) was urinary dysfunction, followed by ileus and surgical site infection (SSI), and none differed by procedure (LS vs. RALS). Univariate analysis showed significant differences in LLND laterality (p = 0.02) and SSI (p = 0.04) between groups S and L. In multivariate analysis, bilateral LLND (p < 0.01, HR 7.37) and SSI (p = 0.01, HR 15.36) were independent factors that worsened DUC. There was no difference in urinary dysfunction after LLND between LS and RALS. Bilateral LLND and SSI were risk factors for lengthening DUC. Compared to bilateral LLND, unilateral LLND can reduce urinary dysfunction; therefore, selective LLND, which is overwhelmingly unilateral LLND, and prevention of perioperative SSI may be important for maintenance of urinary function. |
ArticleNumber | 416 |
Audience | Academic |
Author | Irie, Takahiro Ro, Hisashi Honjo, Kumpei Takahashi, Makoto Takahashi, Hiromitsu Tsukamoto, Ryoichi Kojima, Yutaka Sugimoto, Kiichi Kawai, Masaya Toake, Miyuki Kochi, Saki Sakamoto, Kazuhiro Ishiyama, Shun Tsuchiya, Yuki Amemiya, Kota Momose, Hirotaka |
Author_xml | – sequence: 1 givenname: Makoto surname: Takahashi fullname: Takahashi, Makoto – sequence: 2 givenname: Kazuhiro surname: Sakamoto fullname: Sakamoto, Kazuhiro – sequence: 3 givenname: Hisashi surname: Ro fullname: Ro, Hisashi – sequence: 4 givenname: Saki surname: Kochi fullname: Kochi, Saki – sequence: 5 givenname: Miyuki surname: Toake fullname: Toake, Miyuki – sequence: 6 givenname: Hiromitsu surname: Takahashi fullname: Takahashi, Hiromitsu – sequence: 7 givenname: Takahiro surname: Irie fullname: Irie, Takahiro – sequence: 8 givenname: Hirotaka surname: Momose fullname: Momose, Hirotaka – sequence: 9 givenname: Kota surname: Amemiya fullname: Amemiya, Kota – sequence: 10 givenname: Yuki surname: Tsuchiya fullname: Tsuchiya, Yuki – sequence: 11 givenname: Ryoichi surname: Tsukamoto fullname: Tsukamoto, Ryoichi – sequence: 12 givenname: Kumpei surname: Honjo fullname: Honjo, Kumpei – sequence: 13 givenname: Masaya surname: Kawai fullname: Kawai, Masaya – sequence: 14 givenname: Shun surname: Ishiyama fullname: Ishiyama, Shun – sequence: 15 givenname: Kiichi surname: Sugimoto fullname: Sugimoto, Kiichi – sequence: 16 givenname: Yutaka surname: Kojima fullname: Kojima, Yutaka |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39716123$$D View this record in MEDLINE/PubMed |
BookMark | eNptkltvFCEYhiemxh70D3hhSLzxZiqHYYAr0zQemjTRC70mLDBbNgysMLNm_PV-7ba1awwhfIGHF154T5ujlJNvmtcEnxMi-_eVUKlYi2kHvVei5c-aE9IJ0tJO0qMn9XFzWusGYyIk5y-aY6YE6QllJ83vb7lOeeuLmcLOo7mEZMqC3FKHOdkp5ISGHGP-FdIaRTMBGFFcxu0NStl55EKt_oErqEANgDXJ-oJ2waAxpDCaGBcU0s7U20PqXNa-LC-b54OJ1b-6H8-aH58-fr_80l5__Xx1eXHdWk741BrTOzsMnBlqjXW0F1ww550Ug-MY92CpF4KpQSlFpMCcWkwkddwxhzkh7Ky52uu6bDZ6W-A6ZdHZBH03kctamzIFG73uQMELMii6Mp2wfkU6rrD0jDFOOmVB68NeazuvRu-sTxM8yIHo4UoKN3qdd5qQvu8kp6Dw7l6h5J-zr5MeQ7U-RpN8nqtmpJOyI7LrAX37D7rJc0nwVkBx-HHwrf5SawMOQhoyHGxvRfWFpOBfKC6BOv8PBc35MVjI1RBg_mDDm6dOHy0-RAcAugdsybUWPzwiBOvbfOp9PjXkU9_lU3P2BzqE2E0 |
Cites_doi | 10.1007/s00464-017-5948-4 10.1007/s00268-015-3299-7 10.1007/s00384-021-03858-1 10.1111/ans.18029 10.1007/s00268-016-3762-0 10.1007/s00268-016-3444-y 10.1093/bjsopen/zrae048 10.1007/s10151-020-02383-7 10.21037/jgo.2019.10.03 10.1007/s00464-020-07943-4 10.1097/01.sla.0000133083.54934.ae 10.1007/s00464-021-08364-7 10.1016/j.asjsur.2020.06.010 10.1007/s13193-017-0698-2 10.1097/SLA.0000000000002212 10.23922/jarc.2019-018 10.1002/bjs.11513 10.1007/s00384-016-2640-4 10.1016/j.critrevonc.2023.104196 10.3389/fsurg.2019.00079 10.1016/j.amjsurg.2023.10.046 10.1055/s-0040-1714238 10.1111/ases.13192 10.3892/ol.2024.14214 10.1002/bjs5.50194 10.3748/wjg.v26.i21.2877 10.1016/S0022-3468(97)90702-8 10.1093/jjco/hyac167 10.1245/s10434-021-10312-7 10.1097/DCR.0b013e31822c94e6 10.1007/s00464-020-07979-6 10.1016/j.anclin.2009.07.010 10.1007/s11605-021-05035-9 10.1097/SLE.0000000000000681 10.1007/s00464-024-10901-z 10.4993/acrt.30.106 10.5980/jpnjurol1989.80.1257 10.3855/jidc.15289 10.1371/journal.pone.0304031 10.1007/s00464-024-11111-3 10.3862/jcoloproctology.72.373 10.1007/s11605-020-04825-x |
ContentType | Journal Article |
Copyright | 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7QP 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH K9. M0S M1P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12893-024-02697-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central - New (Subscription) ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1471-2482 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_4918e71f92ba47ceb145908e3335149c PMC11664852 A821137958 39716123 10_1186_s12893_024_02697_5 |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7QO 7QP 7XB 8FD 8FK AZQEC DWQXO FR3 K9. P64 PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c515t-aa6dcff53a2cacd267573ded87fd500678567739f999187052c0182d5d3d05113 |
IEDL.DBID | M48 |
ISSN | 1471-2482 |
IngestDate | Wed Aug 27 01:25:49 EDT 2025 Thu Aug 21 18:30:12 EDT 2025 Mon Jul 21 11:53:20 EDT 2025 Fri Jul 25 22:44:59 EDT 2025 Tue Jun 17 22:00:00 EDT 2025 Tue Jun 10 21:05:55 EDT 2025 Wed Feb 19 01:59:11 EST 2025 Tue Jul 01 01:18:41 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Duration of urinary catheterization Rectal cancer Robot-assisted laparoscopic surgery Removal of urinary catheter Laparoscopic surgery Urinary dysfunction Lateral lymph node resection |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c515t-aa6dcff53a2cacd267573ded87fd500678567739f999187052c0182d5d3d05113 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/3152696779?pq-origsite=%requestingapplication% |
PMID | 39716123 |
PQID | 3152696779 |
PQPubID | 42548 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_4918e71f92ba47ceb145908e3335149c pubmedcentral_primary_oai_pubmedcentral_nih_gov_11664852 proquest_miscellaneous_3148841846 proquest_journals_3152696779 gale_infotracmisc_A821137958 gale_infotracacademiconefile_A821137958 pubmed_primary_39716123 crossref_primary_10_1186_s12893_024_02697_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-12-23 |
PublicationDateYYYYMMDD | 2024-12-23 |
PublicationDate_xml | – month: 12 year: 2024 text: 2024-12-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC surgery |
PublicationTitleAlternate | BMC Surg |
PublicationYear | 2024 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | T Akiyoshi (2697_CR39) 2019; 3 YC Chen (2697_CR28) 2024; 38 G Wakabayashi (2697_CR42) 1997; 52 2697_CR3 2697_CR15 K Erozkan (2697_CR12) 2024; 230 R Du (2697_CR25) 2021; 44 S Fujita (2697_CR8) 2017; 266 HJ Kim (2697_CR30) 2018; 32 S Tsuchida (2697_CR36) 1989; 80 Y Kanemitsu (2697_CR33) 2020; 33 K Kawai (2697_CR35) 2023; 93 A Ishibe (2697_CR2) 2016; 40 J Otero de Pablos (2697_CR5) 2019; 6 T Shigaki (2697_CR22) 2019; 72 SH Song (2697_CR29) 2021; 25 K Koushi (2697_CR47) 2016; 31 R Flouchi (2697_CR44) 2022; 16 H Kawamura (2697_CR32) 2022; 30 JN Chen (2697_CR40) 2020; 26 2697_CR34 S Zhou (2697_CR19) 2023; 53 K Li (2697_CR43) 2021; 25 D Fernández-Martínez (2697_CR17) 2020; 11 RA Wani (2697_CR18) 2017; 8 2697_CR31 S Tsukamoto (2697_CR9) 2020; 107 A Hamabe (2697_CR13) 2024; 8 D Dindo (2697_CR14) 2004; 240 Y Sadakari (2697_CR21) 2022; 36 L Boublikova (2697_CR7) 2023; 192 H Morohashi (2697_CR26) 2021; 35 MA Chaouch (2697_CR20) 2024; 19 B Zou (2697_CR23) 2024; 27 T Manabe (2697_CR38) 2019; 29 K Hida (2697_CR11) 2021; 28 MR Davies (2697_CR37) 1997; 32 Y Nishizawa (2697_CR46) 2011; 54 J Watanabe (2697_CR24) 2021; 35 L Wang (2697_CR16) 2021; 25 DM Darrah (2697_CR48) 2009; 27 AA Iv (2697_CR6) 2022; 35 H Inoue (2697_CR4) 2021; 36 H Nishi (2697_CR45) 2021; 69 T Kinugasa (2697_CR1) 2013; 33 M Obatake (2697_CR27) 2023; 16 A Ogura (2697_CR41) 2017; 41 H Ozawa (2697_CR10) 2016; 40 |
References_xml | – volume: 32 start-page: 2466 issue: 5 year: 2018 ident: 2697_CR30 publication-title: Surg Endosc doi: 10.1007/s00464-017-5948-4 – volume: 40 start-page: 995 issue: 4 year: 2016 ident: 2697_CR2 publication-title: World J Surg doi: 10.1007/s00268-015-3299-7 – volume: 36 start-page: 1263 issue: 6 year: 2021 ident: 2697_CR4 publication-title: Int J Colorectal Dis doi: 10.1007/s00384-021-03858-1 – volume: 93 start-page: 206 issue: 1–2 year: 2023 ident: 2697_CR35 publication-title: ANZ J Surg doi: 10.1111/ans.18029 – volume: 41 start-page: 868 issue: 3 year: 2017 ident: 2697_CR41 publication-title: World J Surg doi: 10.1007/s00268-016-3762-0 – volume: 40 start-page: 1492 issue: 6 year: 2016 ident: 2697_CR10 publication-title: World J Surg doi: 10.1007/s00268-016-3444-y – volume: 8 start-page: zrae048 issue: 3 year: 2024 ident: 2697_CR13 publication-title: BJS Open doi: 10.1093/bjsopen/zrae048 – volume: 25 start-page: 413 issue: 4 year: 2021 ident: 2697_CR29 publication-title: Tech Coloproctol doi: 10.1007/s10151-020-02383-7 – volume: 11 start-page: 91 issue: 1 year: 2020 ident: 2697_CR17 publication-title: J Gastrointest Oncol doi: 10.21037/jgo.2019.10.03 – volume: 35 start-page: 4427 issue: 8 year: 2021 ident: 2697_CR24 publication-title: Surg Endosc doi: 10.1007/s00464-020-07943-4 – volume: 240 start-page: 205 issue: 2 year: 2004 ident: 2697_CR14 publication-title: Ann Surg doi: 10.1097/01.sla.0000133083.54934.ae – volume: 36 start-page: 999 issue: 2 year: 2022 ident: 2697_CR21 publication-title: Surg Endosc doi: 10.1007/s00464-021-08364-7 – volume: 44 start-page: 26 issue: 1 year: 2021 ident: 2697_CR25 publication-title: Asian J Surg doi: 10.1016/j.asjsur.2020.06.010 – volume: 8 start-page: 499 issue: 4 year: 2017 ident: 2697_CR18 publication-title: Indian J Surg Oncol doi: 10.1007/s13193-017-0698-2 – volume: 266 start-page: 201 issue: 2 year: 2017 ident: 2697_CR8 publication-title: Ann Surg doi: 10.1097/SLA.0000000000002212 – volume: 33 start-page: 2921 issue: 7 year: 2013 ident: 2697_CR1 publication-title: Anticancer Res – ident: 2697_CR3 doi: 10.23922/jarc.2019-018 – volume: 107 start-page: 586 issue: 5 year: 2020 ident: 2697_CR9 publication-title: Br J Surg doi: 10.1002/bjs.11513 – volume: 31 start-page: 1845 issue: 12 year: 2016 ident: 2697_CR47 publication-title: Int J Colorectal Dis doi: 10.1007/s00384-016-2640-4 – volume: 192 start-page: 104196 year: 2023 ident: 2697_CR7 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2023.104196 – volume: 6 start-page: 79 year: 2019 ident: 2697_CR5 publication-title: Front Surg doi: 10.3389/fsurg.2019.00079 – volume: 230 start-page: 91 year: 2024 ident: 2697_CR12 publication-title: Am J Surg doi: 10.1016/j.amjsurg.2023.10.046 – volume: 33 start-page: 349 issue: 6 year: 2020 ident: 2697_CR33 publication-title: Clin Colon Rectal Surg doi: 10.1055/s-0040-1714238 – ident: 2697_CR34 – volume: 16 start-page: 455 issue: 3 year: 2023 ident: 2697_CR27 publication-title: Asian J Endosc Surg doi: 10.1111/ases.13192 – volume: 27 start-page: 80 issue: 2 year: 2024 ident: 2697_CR23 publication-title: Oncol Lett doi: 10.3892/ol.2024.14214 – volume: 3 start-page: 822 issue: 6 year: 2019 ident: 2697_CR39 publication-title: BJS Open doi: 10.1002/bjs5.50194 – volume: 69 start-page: 216 year: 2021 ident: 2697_CR45 publication-title: Jpn J Occup Med Traumatol – ident: 2697_CR15 – volume: 26 start-page: 2877 issue: 21 year: 2020 ident: 2697_CR40 publication-title: World J Gastroenterol doi: 10.3748/wjg.v26.i21.2877 – volume: 32 start-page: 536 issue: 4 year: 1997 ident: 2697_CR37 publication-title: J Pediatr Surg doi: 10.1016/S0022-3468(97)90702-8 – volume: 35 start-page: 226 issue: 3 year: 2022 ident: 2697_CR6 publication-title: Ann Gastroenterol – volume: 53 start-page: 26 issue: 1 year: 2023 ident: 2697_CR19 publication-title: Jpn J Clin Oncol doi: 10.1093/jjco/hyac167 – volume: 28 start-page: 6179 issue: 11 year: 2021 ident: 2697_CR11 publication-title: Ann Surg Oncol doi: 10.1245/s10434-021-10312-7 – volume: 52 start-page: 575 year: 1997 ident: 2697_CR42 publication-title: J Clin Surg – volume: 54 start-page: 1423 issue: 11 year: 2011 ident: 2697_CR46 publication-title: Dis Colon Rectum doi: 10.1097/DCR.0b013e31822c94e6 – volume: 35 start-page: 5001 issue: 9 year: 2021 ident: 2697_CR26 publication-title: Surg Endosc doi: 10.1007/s00464-020-07979-6 – volume: 27 start-page: 465 issue: 3 year: 2009 ident: 2697_CR48 publication-title: Anesthesiol Clin doi: 10.1016/j.anclin.2009.07.010 – volume: 25 start-page: 2726 issue: 10 year: 2021 ident: 2697_CR43 publication-title: J Gastrointest Surg doi: 10.1007/s11605-021-05035-9 – volume: 29 start-page: 493 issue: 6 year: 2019 ident: 2697_CR38 publication-title: Surg Laparosc Endosc Percutan Tech doi: 10.1097/SLE.0000000000000681 – volume: 38 start-page: 3520 issue: 7 year: 2024 ident: 2697_CR28 publication-title: Surg Endosc doi: 10.1007/s00464-024-10901-z – volume: 30 start-page: 106 issue: 2 year: 2022 ident: 2697_CR32 publication-title: Ann Cancer Res Ther doi: 10.4993/acrt.30.106 – volume: 80 start-page: 1257 issue: 9 year: 1989 ident: 2697_CR36 publication-title: Jpn J Urol doi: 10.5980/jpnjurol1989.80.1257 – volume: 16 start-page: 1191 issue: 7 year: 2022 ident: 2697_CR44 publication-title: J Infect Dev Ctries doi: 10.3855/jidc.15289 – volume: 19 start-page: e0304031 issue: 5 year: 2024 ident: 2697_CR20 publication-title: PLoS ONE doi: 10.1371/journal.pone.0304031 – ident: 2697_CR31 doi: 10.1007/s00464-024-11111-3 – volume: 72 start-page: 373 issue: 6 year: 2019 ident: 2697_CR22 publication-title: J Jpn Soc Coloproctol doi: 10.3862/jcoloproctology.72.373 – volume: 25 start-page: 1866 issue: 7 year: 2021 ident: 2697_CR16 publication-title: J Gastrointest Surg doi: 10.1007/s11605-020-04825-x |
SSID | ssj0017855 |
Score | 2.3572316 |
Snippet | Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there are some... Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there... BackgroundLateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence. However, there... Abstract Background Lateral lymph node dissection (LLND) for locally advanced rectal cancer (LARC) is performed widely since it reduces local recurrence.... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 416 |
SubjectTerms | Abdomen Adult Aged Aged, 80 and over Cancer Cancer surgery Cancer therapies Catheterization Catheters Colorectal cancer Complications Dissection Duration of urinary catheterization Female Health aspects Humans Intubation Laparoscopic surgery Laparoscopy Laparoscopy - adverse effects Laparoscopy - methods Lateral lymph node resection Lymph Node Excision - adverse effects Lymph Node Excision - methods Lymph nodes Lymphatic system Male Medical instruments Metastasis Middle Aged Minimally invasive surgery Multivariate analysis Patients Postoperative Postoperative Complications - epidemiology Postoperative Complications - etiology Postoperative Complications - prevention & control Rectal Neoplasms - surgery Rectum Removal of urinary catheter Retrospective Studies Risk Factors Robot-assisted laparoscopic surgery Robotic surgery Robotic Surgical Procedures - adverse effects Robotic Surgical Procedures - methods Surgical site infections Urinary Catheterization Urinary dysfunction Urination Disorders - epidemiology Urination Disorders - etiology Urination Disorders - prevention & control Urine |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LixNBEG5kT15E8TW6SguCBxk2_e4-ruKyCHpyYW9NTz8wMM4sSXaX-OutmkfI4MGLh1zSFZiud2WqviLkfRJSNDzmOluxqqUNsnaR6bppsjTCpmIZzg5_-64vr-TXa3V9tOoLe8JGeOCRcWfSMZsNK443QZoIrkXimu4sBPagu4jeF2LeXExN7w-MVWoekbH6bAteGPvUuISPdqZWizA0oPX_7ZOPgtKyYfIoAl08Jo-m1JGej4_8hDzI3VPyG7ft9jd5BPCm-N952Oxp2m8xYiHXaQFR9_cQomgbcN64pe0eZEi7PmU6vI-f6TYU_R8QRNSFDb1bB4rYI79C2-7pursL2OxOt-Mo9TNydfHlx-fLetqnUEfIWnZ1CDrFUpQIPIaYONQKRqScrClJDWFLaWOEK5g0gh0rHldQfiSVRALbZeI5Oen6Lr8k1CQhtAtNRrAYWQyIVudViJyVpFnhFfk4s9ffjLAZfig3rPajMDwIww_C8Koin1ACB0qEvB6-AEXwkyL4fylCRT6g_DwaJggJbjjOF8ADI8SVP7dQ6wrjlK3I6YISDCouj2cN8JNBb71guIod2OMq8u5wjL_EJrUu97dIA95QQsmsK_JiVJjDlQRCdUGWUBG7UKXFnZcn3frnAPfNmNbSKv7qf3DpNXnI0QwYr7k4JSe7zW1-A2nVrnk7WNAfGMAg6A priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Li9RAEG50vXgRxVd0lRYEDxJ20u-cZBWXRdCTC3NrOv3QgZiMyewus7_eqjzGDYKHXNIV6O56dXWqviLkbeCCV8zHPBq-yoVxIi99ofKqikJzE5IpsHb46zd1fiG-rOV6unDrp7TK2SYOhjq0Hu_IT3iBvbCV1uWH7e8cu0bh39WphcZdcg-hyzD40utDwIWN5-VcKGPUSQ-2GLPVmIBHlTqXC2c0YPb_a5lvuaZl2uQtP3T2kDyYDpD0dOT4I3InNo_JDfbcbbdxhPGmeIPuuj0N-x79Fu49TcDw9hocFa0dVh3XtN4DJ2nThkiHv_IzXUfRCgKBR4no6NXGUUQg-eXqek83zZXDlHfajwXVT8jF2efvn87zqatC7uHsssudU8GnJLlj3vnAIGLQPMRgdApycF4SdpmXCY-OoM2S-RUEIUEGHkCDC_6UHDVtE58TqgPnqnRVRMgYkTQwWMWV86xIQRWJZeT9vL12O4Jn2CHoMMqOzLDADDsww8qMfEQOHCgR-Hp40XY_7KRHVsCcoi5SySontAdPI7Bre-QcSxJKn5F3yD-L6glMghWOVQYwYQS6sqcGIl6uS2kycrygBLXyy-FZAuyk1r39K4QZeXMYxi8xVa2J7SXSgE0UEDirjDwbBeawJI6AXXBWyIhZiNJizcuRZvNzAP0uCqWEkezF_-f1ktxnKOAFyxk_Jke77jK-gmPTrno96MYfY0kZeg priority: 102 providerName: ProQuest |
Title | Postoperative urinary dysfunction following lateral lymph node dissection for rectal cancer via minimally invasive surgery |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39716123 https://www.proquest.com/docview/3152696779 https://www.proquest.com/docview/3148841846 https://pubmed.ncbi.nlm.nih.gov/PMC11664852 https://doaj.org/article/4918e71f92ba47ceb145908e3335149c |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3da9RAEF_6AdIXUfyK1mMFwQeJXvY7DyI9aSlCixQPDl-Wze6mHsSc5q7V8693JrmcDdaH5CE7Cdn9_WZnJ9mZIeRl4IIXzMc0Gj5OhXEizX2m0qKIQnMTSpNh7PDZuTqdio8zOdshfbmjzQAub3XtsJ7UtKne_Pqxfg8K_65VeKPeLmGOxV1oTMChcp3KXbIPlkljKYcz8fevgjZS9oEzt953QO5wzKmUMT6wU206_38n7RtWa7ij8oaJOrlH7m7WlvSoI8N9shPrB-Q3luOFPnUZvil-XHfNmob1Ek0awkJL4MLiJ9gwWjkMSK5otQaQab0IkbY_7Hu5huIECQIeydLQ67mjmJzkm6uqNZ3X1w53w9NlF2v9kExPjj9_OE03BRdSD8uaVeqcCr4sJXfMOx8YOBOahxiMLoNs7ZpUWvO8xFUlKLpkfgz-SZCBB1DujD8ie_Wijk8I1YFzlbsiYjYZUWrAXsWx8ywrg8pKlpDX_fDa711eDdv6I0bZDhcLuNgWFysTMkEEtpKYE7u9sGgu7UbFrIB3ijorc1Y4oT0YIYEF3SPnGK2Q-4S8QvwscglAgh52AQjwwpgDyx4ZcIa5zqVJyOFAEjTOD5t7BtiesJZnWKsdhidPyIttM96Ju9jquLhCGZguBfjUKiGPO8Jsu9TzLiFmQKVBn4ct9fxrmw88y5QSRrKn_33oM3LAkOYZSxk_JHur5io-h8XUqhiRXT3TI7I_OT7_dDFqP0mMWq2B88Xkyx-CHCDs |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9gAXBOIVKGAkEAcUdeNnckCohVZb2q4QaqXejGM7ZaWQLLvbVsuP4jcyk2yWRkjcesglHie25_PMOJkHIa89FzxnLsQh5cNYpFbEmUtUnOdBaJ76Ik0wdvh4rEan4vOZPNsgv7tYGHSr7GRiI6h97fAb-TZPsBa20jr7MP0ZY9Uo_LvaldBoYXEYlldwZJu_P_gE_H3D2P7eycdRvKoqEDvQ3YvYWuVdUUhumbPOM7CYNffBp7rwshHeEt7CswJNJ0CzZG4IRriXnntAcMLhubfIpuBgKgzI5u7e-MvX9X8L6Cy70JxUbc9B-qN_HBNwqUzHsqf-mioB_-qCa8qw76h5TfPt3yN3VyYr3Wkxdp9shOoB-YVVfutpaBOHU_xmb2dL6pdz1JTIbVoAxOorUI20tBjnXNJyCdihVe0DbfwAOroZRbkLBA4xOKOXE0sx58kPW5ZLOqkuLTrZ03kbwv2QnN7Iij8ig6quwhNCtedcZTYPmKRGFBogpcLQOpYUXiUFi8i7bnnNtE3XYZpjTqpMywwDzDANM4yMyC5yYE2JqbabG_Xs3Kx2rhEwpqCTImO5FdqBbhNYJz5wjkEQmYvIW-SfQYEATIIZtnENMGBMrWV2Ujhjc53JNCJbPUrYyK7f3CHArATJ3PyFfURerZuxJzrHVaG-QBqQwgKO6ioij1vArKfEMUUYWCcRSXtQ6s2531JNvjdpxpNEKZFK9vT_43pJbo9Ojo_M0cH48Bm5wxDsCYsZ3yKDxewiPAejbZG_WO0USr7d9Ob8A4UPVn0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Postoperative+urinary+dysfunction+following+lateral+lymph+node+dissection+for+rectal+cancer+via+minimally+invasive+surgery&rft.jtitle=BMC+surgery&rft.au=Takahashi%2C+Makoto&rft.au=Sakamoto%2C+Kazuhiro&rft.au=Ro%2C+Hisashi&rft.au=Kochi%2C+Saki&rft.date=2024-12-23&rft.eissn=1471-2482&rft.volume=24&rft.issue=1&rft.spage=416&rft_id=info:doi/10.1186%2Fs12893-024-02697-5&rft_id=info%3Apmid%2F39716123&rft.externalDocID=39716123 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2482&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2482&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2482&client=summon |